Blog: You, us, everyone

Welcome to our blog – a place to discuss and exchange thoughts and ideas about iX-7 Asset Management SA, the stock markets and all matters relating to wealth management.


Article
Saturday, October 15, 2022 by Christoph.Schmid|Comment 0
within category Chemicals,Agrochemical,Pharma,ESG

Bayer's rock-bottom sentiment and valuation continue to offer a credible, de-risked entry point, in our view. The stock trades below 9x 2023E P/E. Bayer's relatively cautious guidance for 2022 is too conservative, as agro markets in particular have sustainably rebounded, backed by strong crop prices. Pharma: while Eylea and Xarelto are faced with patent loss, their respective sales are holding up better than expected so far, and Bayer has a broader pipeline of new compounds with >EUR5bn of peak sales. Any kind of change can only be good news: litigation progress, activism, ESG improvement.

Catalysts:

  • Confirmation from Bayer of a brighter crop market outlook.
  • Progress on glyphosate litigation.
  • Next quarterly report to provide further clarity on improving earnings momentum.
Comments
Not commented yet? Be the first to post a comment.
Current pageTotal pages 0
Comments per page
select
Add a comment
Author:
Email: Help
Related articles
Saturday, October 15, 2022
DuPont de Nemours is a world-renowned specialty chemicals company with a history spanning over 200 years and an ever-evolving portfolio. In the current iteration, DuPont is the specialty chemicals co…
More …

Saturday, April 23, 2022
Très mauvais trimestre pour la société puisque la mine de cuivre de Los Pelambres est affectée par la sécheresse au Chili.
More …

Monday, May 26, 2014
Unlocking investment value in BHP - Description: BHP Billiton (BHP) is the world’s largest mining company with operations across the globe. The group has a unique business model, being the only re…
More …
iX-7 Asset Management SA, access to financial information is a right. Knowledge is power.